Impact of chirality on drug action

Journal of the Indian Chemical Society

Volumn 83, Issue 4, 2006, Pages 315-326

  Sangita, ^a   Ray, S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Chirality; Drug action; Receptor; Review

Indexed keywords

AMFEBUTAMONE; AMLODIPINE; ATROPINE; CANDOXATRIL; CAPTOPRIL; CENTCHROMAN; CETIRIZINE; CHLORAMPHENICOL; CISAPRIDE; DEVAZEPIDE; DOXAZOSIN; ENALAPRIL; EZETIMIBE; IBUPROFEN; LABETALOL; LERCANIDIPINE; LOXIGLUMIDE; NAPROXEN; OMAPATRILAT; ONDANSETRON; OXYBUTYNIN; PENICILLAMINE; PIOGLITAZONE; ROSIGLITAZONE; SAQUINAVIR; SIBUTRAMINE; THALIDOMIDE; TICALOPRIDE; TROGLITAZONE; UNINDEXED DRUG; ZOPICLONE;

BIOLOGICAL ACTIVITY; BIOTRANSFORMATION; BIRTH DEFECT; BLINDNESS; CHIRALITY; CLEFT PALATE; DEFORMITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENANTIOMER; HEARING IMPAIRMENT; HUMAN; LIGAND BINDING; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STEREOCHEMISTRY; TERATOGENICITY; WILSON DISEASE;

EID: 33646833951     PISSN: 00194522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. K. Williams and E. Lee, Drugs, 1985, 30, 333.
2. H. Shindo and J. Caldwell, Chirality, 1995, 7, 349.
3. V. M. Potapov, "Stereochemistry", Khimia, Moscow, 1988.
4. J. Solms, L. Vuataz and R. H. Egli, Experientia, 1965, 21, 692.
5. S. S. Schiffman, T. B. Clark and Gagon, J. Physiol. Behav., 1982, 28, 457.
6. M. Laska and P. Teubner, Chem. Senses., 1999, 24, 161.
7. E. H. Polak, A. M. Fombon, C. Tilquin and P. H. Punter, Behav. Brain. Res., 1989, 31, 199.
8. W. H. DeCamp, Chirality, 1989, 1, 2.
9. A. J. Hutt and S. C. Tan, Drug, 1996, 52, 1.
10. N. Kurihara, J. Miyamoto, G. D. Paulson, B. Zeeh, M. W. Skidmore, R. M. Hollingworth and H. A. Kuiper, Pure Appl. Chem., 1997, 69, 1335.
11. D. Voet and J. G. Voet, "Biochemistry", 2nd ed., 1995, Vol. 64.
12. Roger M. Lane and Glen B. Baker, Cell. Mol. Neu., 1999, 19, 355.
13. S. C. Stinson. Chem. Eng. News, 2000, 78, 43.
14. B. Testa, "Principles of Organic Stereochemistry", Dekker, New York, 1979.
15. B. Testa, in "Stereochemistry", ed. Ch. Tamm, Elsevier Biomedical Press, Amsterdam, 1982, p. 1.
16. D. E. Drayer, Clin. Pharm. Ther., 1986, 40, 125.
17. H. M. Lambert Janssen, Bioorg. Med. Chem., 1998, 6, 785.
18. A. Korolkovas, "Essentils of Molecular Pharmacology", Wiley-Interscience, New York, 1970.
19. M. E. Wolff, W. Ho and R. Kwok, J. Med. Chem., 1964, 7, 577.
20. P. Gund, Prog. Cell. Mol. Biol., 1970, 117.
21. P. Erhlich, Chem. Ber., 1909, 42, 17.
22. R. J. Walker and J. P. Fawcett, Prog. Drug. Res., 1993, 41, 51.
23. Suprabhat Ray, Reema Rastogi and Atul Kumar, Prog. Drug. Res., 2002, 59, 202.
24. "Medicinal Chemistry - A Biochemical Approach", ed. T. Nogrady, Oxford University Press, 1985, p. 3.
25. B. G. Katzung, "Basic Principles: Introduction in Basic and Clinical Pharmacology", ed. B. G. Katzung, Appleton-Longe, 1998, p. 1.
26. H. G. Mautner, Pharmacol. Rev., 1967, 19, 107.
27. C. C. Pfeiffer, Science, 1956, 124, 29.
28. "Burger's Medicinal Chemistry". 4th ed., Part I, 'The basis of medicinal chemistry', ed. M. E. Wolff, Chap. 6.
29. 'Drug-Receptor Geometry', Kuntz. I.E., p. 285.
30. A. J. Clark, "General Pharmacology" in: 'Heffter's Hand buch der experimentellen pharmakologie', eds. W. Heubner and T. Erg Schuller, Springer, Berlin, 1973a, Vol. 4.
31. A. J. Clark, "The Mode of Action of Drugs on Cells", eds. Baltimore, Williams and Wilkins, 1937b.
32. E. J. Ariens and A. M. Simonis, J. Pharm. Pharmacol., 1964, 16, 137.
33. "Molecular Pharmacology", 'The mode of action of biologically active compound', ed. E. J. Ariens, 1964, 1. Sect. IIA;
34. "Drug Receptor Interaction", 'Interaction of one or more drugs with one receptor system', eds. E. J. Ariens and A. M. Simonis. Incorporation with J. M. van Rossum, p. 119.
35. H. Eyring, L. L. Jones and J. D. Spikes, in "Horizons in Biochemistry", eds. M. Kasha and B. Pullman, Academic Press, New York, p. 229.
36. M. Kenneth Williams, Adv. Pharmacol., 1991, 22, 57.
37. L. R. Low and N. Castagnoli, Annu. Rep. Med. Chem., 1978, 13, 304.
38. A. H. Beckett, Fortschr. Arzne., 1959, 1, 455.
39. A. L. M. Kerremans, Neth. J. Med., 1993, 42, 80.
40. B. W. J. Ellenbroek and J. M. van Rossum. Arch. Intern. Pharmacodynamie, 1960, 125, 216.
41. C. M. Kagawa, F. M. Sturtevant and C. G. van Arman, J. Pharmacol. Expt. Therap., 1959, 126, 123.
42. A. Brossi, Med. Res. Rev., 1994, 14, 665.
43. E. J. Ariens, "Stereoselectivity in Bioactive Agents: General Aspects", in 'Stereochemistry and biological activity of drugs', eds. E. J. Ariens, W. Soudijn and P. B. Timmermans, Blackwell Scientific Publications, Oxford, London, 1983, p. 11.
44. B. Testa, P. A. Carrupt, L. Christiansen, P. Christoffersen and M. Reist, Trends Drug Res., 1993, 20, 1.
45. F. Lehmann, "Receptors and Recognition", eds. P. Cuatrecasas and M. Greaves, Chapman and Hall, London, 1978, 5 (series 4), 1.
46. A. H. Beckett and A. F. Casy, J. Pharm. Pharmacol., 1954, 6, 986.
47. M. Simonyi, Med. Res. Rev., 1984, 4, 359.
48. B. Testa, Trends Pharmacol. Sci., 1986, 7, 60.
49. T. Walle and U. K. Walle, Trends Pharmacol. Sci., 1986, 7, 155.
50. M. Eichelbaum, Biochem. Pharmacol., 1988, 37, 93.
51. F. Jamali, R. Mehvar and F. M. Pasutto, J. Pharm. Sci., 1989, 78, 695.
52. G. T. Tucker and M. Lennard, Pharmac. Ther., 1990, 45, 309.
53. E. J. Ariens, Eur. J. Clin. Pharmacol., 1984, 26, 663.
54. E. J. Ariens, E. W. Wuis and E. J. Verigana, Biochem. Pharmacol., 1988, 37, 9.
55. S. Mason, New Sci., 1984, 1393, 10.
56. F. W. Rosa, Teratology, 1986, 33, 127.
57. S. Miyagawa, A. Yoshioka, M. Hatoko, T. Okuchi and K. Sakamoto, Br. J. Dermatol., 1987, 116, 95.
58. G. J. Brewer, Drugs, 1995, 50, 240.
59. E. E. Santos Silva, J. Sarles, J. P. Buts and E. M. Sokal, J. Pediatr., 1996, 128, 285.
60. T. F. Yu, J. Roboz, S. Johnson and C. Kaung, J. Rheumatol., 1984, 11, 467.
61. V. A. R-T, Arzneim-Forsch. (Drug Res.), 1974, 24, 914.
62. H. G. Taylor and A. Samanta, Drug Safety, 1992, 7, 46.
63. H. E. Haward-Lock, C. J. L. Lock, A. Mewa and W. F. Kean, Semin. Arthritis Reum., 1986, 15, 261.
64. V. D. Steen, S. Blair and T. A. Medsger, Ann. Intern. Med., 1986, 104, 699.
65. W. F. Kean, C. J. L. Lock and H. E. Haward-Lock, Lancet, 1991, 338, 1565.
66. W. Hunkeler, Chimica, 1993, 47, 141.
67. R. Mechoulam, J. J. Feigenbaum, N. Lander, M. Segal, T. U. Jarbe, A. J. Hiltunen and P. Consroe, Experientia, 1988, 44, 762.
68. S. Fabro, R. L. Smith and R. T. Williams, Nature, 1967, 215, 296.
69. G. Casini and M. Ferappi, Farmaco. Ed. Sci., 1964, 19, 563.
70. Y. F. Shealy, C. E. Opliger and J. A. Montgomery, Chem. Indust., 1965, 1030.
71. L. P. De Souza, Br. Med. J., 1959, 2, 635.
72. G. Neuhaus and K. Ibe, Med. Klinik., 1960, 55, 544.
73. D. M. Burley, Med. World, 1960, 93, 26.
74. R. C. A. Fredrickson, I. H. Slater, W. E. Dusenberry, C. R. Hews, G. T. Jones and R. A. Moore, J. Pharmacol Exp. Ther., 1977, 203, 240.
75. K. I. Kaitin, Diss. Abst. Int., 1982, 43, 1811.
76. A. L. Florence, Br. Med. J., 1960, 2, 1954.
77. D. Burley, Br. Med. J., 1961, 1, 130.
78. K. H. Schulz and M. Jänner, Allergic Asthma, 1963, 9, 226.
79. J. Kimming, Verh. Deutsch. Ges. Inn. Med., 1961, 67, 486.
80. K. Hellmann, Lancet, 1966, 1, 1136.
81. K. Hellmann, Wien. Med. Wochenschr., 1967, 117, 415.
82. T. Chard, Lancet, 1966, 1, 1373.
83. R. C. Hastings, Ethiop. Med. J., 1980, 18, 65.
84. R. C. Hastings, M. J. Morales and E. J. Schannon, Pharmacologist, 1976, 18, 569.
85. R. L. Barnhil and A. C. Mc Dougall, J. Am. Acad. Dermatol., 1982, 7, 317.
86. J. M. Miller, M. Ginsberg, G. C. Mc Elfatrick and I. L. Shonberg, Antibiot. Med. Clin. Ther., 1960, 7, 743.
87. R. C. Hastings and M. J. Morales, Int. J. Leprosy, 1973, 41, 494.
88. T. Hunziker and A. Krebs, Hautarzt., 1983, 34, 66.
89. V. P. Kamboj, S. Ray and B. N. Dhawan, Drugs Today, 1992, 28, 227.
90. V. C. Jordan and C. S. Murphy. Endocr. Rev., 1990, 11, 578.
91. B. J. Furr and V. C. Jordan, Pharmacol. Ther., 1984, 25, 127.
92. N. Anand and S. Ray, Ind. J. Exp. Biol., 1977, 15, 1142.
93. M. Salman, S. Ray, N. Anand, A. K. Agarwal, M. M. Singh, B. S. Selty and V. P. Kamboj, J. Med. Chem., 1986, 29, 1801.
94. M. M. Singh, Med. Res. Rev., 2001, 21, 302.
95. N. Srivastava, S. Ray, I. Dwivedi, S. R. Wilson, R. K. Hom and J. A. Katzenellenbogen, Biorg. Med. Chem. Lett., 1996, 6, 1747.
96. A. Mukhopadhyay, S. Gupta, S. Ray and A. K. Giri, Cancer Lett., 1999, 144, 137.
97. S. Ray, A. Tandon, I. Dwivedi, S. R. Wilson, J. P. O'Neil and J. A. Katzenellenbogen, J. Med. Chem., 1994, 37, 696.
98. K. K. Chen and C. H. Kao, J. Am. Pharm. Assoc., 1926, 15, 625.
99. R. H. F. Manske and T. B. Johnson, J. Am. Chem. Soc., 1929, 51, 580, 1906.
100. Karl Freudenberg, Eugene Schoeffel and Emil Braun, J. Am. Chem. Soc., 1932, 54, 234.
101. K. Freudenberg and F. Nikolai, Ann., 1934, 510, 223.
102. B. Witkop and C. M. Foltz, J. Am. Chem. Soc., 1957, 79, 197.
103. R. A. Hahn, J. B. Lapidus, A. Tye and J. W. Nelson, J. Pharm. Sci., 1965, 54, 378.
104. Jules B. LaPidus, Arthur Tye, Popat Patil and Balakrishna A. Modi, J. Med. Chem., 1963, 6, 76.
105. K. Freudenberg, E. Schoeffel and E. Braun, J. Am. Chem. Soc., 1932, 54, 234.
106. Dion R. Brocks and Reza Mehvar, Clinical Pharmacokinetics, 2003, 42, 1359.
107. Dion R. Brocks, Majid Vakily and Reza Mehvar, Chirality in Drug Design and Development, 2004, 191.
108. R. R. Ruffolo (Jr.), "Stereoselectivity in Adrenergic Agonists and Adrenergic Blocking Agents", in 'Stereochemistry and biological activity of drugs', eds. E. J. Ariens, W. Soudijn and P. B. Timmermans, Blackwell Scientific Publictions, Oxford, 1983, p. 103.
109. F. P. Luduena, Arch. d'inter. Phauma., 1962, 87, 155.
110. J. K. Barton, Science, 1986, 233, 727.
111. S. K. Sengupta, D. P. Rosenbaum, R. K. Sehga, B. Almassian and J. Blondin, J. Med. Chem., 1988, 31, 1540.
112. M. S. Lennard, G. T. Tucker, J. H. Silas and H. F. Woods, Xenobiotica, 1986, 16, 435.
113. Kanneth M. Williams, Clin. Exp. Pharmacol. Physiol., 1989, 16, 465.
114. E. J. Ariens, Med. Res. Rev., 1986, 6, 451.
115. Bertil Waldeck, Chirality, 1993, 5, 350.
116. S. C. Stinson, Chem. Eng. News, October 1 (2001), 79.
117. Jindra Valentova and A. J. Hutt, Ceska a Slovenska Farmacie, 2004, 53, 285.
118. Michael J. Cannarsa, Chimica Oggi, 1999, 17, 28.
119. I. Szelenyi, G. Geisslinger, E. Polymeropoulos, W. Paul, M. Herbst and K. Brune, Drug News & Perspective, 1998, 11, 139.
120. S. C. Stinson, Chem. Eng. News, October 23 (2000), 55.
121. Ramesh N. Patel, Advances in Applied Microbiology, 1997, 43, 91.
122. Honore Monti and Gerard Audran. Mini-Reviews in Organic Chemistry, 2005, 2, 265.
123. Shaoyi Chen, Xiu Yang and Yujing Qin, Shengwu Gongcheng Jinzhan, 2000, 20, 60.
124. I. Tegeder, K. Williams and G. Geisslinger, "Metabolic Chiral Inversion of 2-Arylpropionic Acids. Handbook of Experimental Pharmacology" (Stereochemical Aspects of Drug Action and Disposition), 2003, 153, pp. 341-354.
125. Andrew J. Hutt and John Caldwell, Journal of Pharmacy and Pharmacology, 1983, 35, 693.
126. Neal M. Davies, Chirality in Drug Design and Development, 2004, 351.
127. Haiping Hao, Guangji Wang and Jianguo Sun, Drug Metabolism Reviews, 2005, 37, 215.
128. V. Wsol, L. Skalova and B. Szotakova, Current Drug Metabolism, 2004, 5, 517.
129. S. S. Adams, P. Breloff and C. G. Mason, J. Pharm. Pharmacol., 1976, 28, 256.
130. R. D. Carmer III, D. E. Patterson and J. D. Bunce, J. Am. Chem. Soc., 1988, 110, 5959.
131. G. R. Marshall and R. D. Cramer, Trends Pharmacol. Sci., 1988, 9, 285.
132. A. Golbraikh, D. Bonchev and A. Tropsha, J. Chem. Inf. Comput. Sci., 2001, 41, 147.
133. J. V. de Julián-Ortiz, C. de G. Alapont, I. Rios-Santamarina, R. Garcia-Doménech and J. Gàlvez, J. Mol. Graphic Mod., 1998, 16, 14.
134. A. Kovatcheva, A. Golbraikh, S. Oloff, J. Feng, W. Zheng and A. Tropsha, SAR and QSAR in Environmental Research, 2005, 16, 93.
135. A. Golbraikh and A. Tropsha, J. Chem. Inf. Comput. Sci., 2003, 43, 144.
136. L. Dinan, R. E. Hormann and T. Fujimoto, J. Comput. Aided Mol. Des., 1999, 13, 185.
137. W. J. Lambert and P. G. Timmer, Pharm. Res., 1991, 8, 1944.
138. Bezhan Chankvetadze, "Recent Trends in Enantioseparation of Chiral Drugs. Methods and Principles in Medicinal Chemistry". (Molecular Biology in Medicinal Chemistry), 2004, 21, pp. 181-210.
139. Bezhan Chankvetadze and Jacques Crommen, Journal of Pharmaceutical and Biomedical Analysis, 2001, 27, 355.
140. Hong-xia Li, Wei Li and Xue-xin Gu, Huaxue Yanjiu, 2005, 16, 96.
141. Robert J. Pascoe, Alicia G. Peterson and Joe P. Foley, Electrophoresis, 2000, 21, 2033.
142. S. C. Stinson, Chem. Eng. News, 1992, 46.